Remove 2029 Remove Communication Remove FDA
article thumbnail

Top Performing Drug of 2021 - Trulicity (February Edition)

PharmaShots

Some of its FDA-approved competitors include: Patents7 Eli Lilly carries big expectations from Trulicity to boost its revenue. Those with Medicare or Medicaid coverage are not eligible. Trulicity Competitors6 There are many other alternative types of diabetes medications present in the market that gives tough opposition to Trulicity.

article thumbnail

Intercept receives orphan drug designation for liver disease combo therapy

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has awarded an orphan drug designation to Intercept Pharmaceuticals’ fixed-dose combination of obeticholic acid and bezafibrate for the treatment of primary biliary cholangitis. Data from the analyses will be used for a potential end-of-Phase II study meeting with the FDA. billion in 2029.

FDA 52